Back to top
more

Catalent (CTLT)

(Real Time Quote from BATS)

$109.98 USD

109.98
464,973

+0.04 (0.04%)

Updated Aug 12, 2022 02:55 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.75%
2Buy18.15%
3Hold9.70%
4Sell5.35%
5Strong Sell2.45%
S&P50010.91%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 252)

Industry: Medical - Drugs

Trades from $1

Company Summary

Somerset, NJ-based Catalent, Inc. is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Catalent operates through four arms:

Biologics (48.2% of aggregate revenues in FY 2021, up 88.8% on a reported basis from FY 2020): The segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing; formulation, development, and manufacturing of parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services for large molecules. Further, the growing ...

General Information

Catalent, Inc

14 SCHOOLHOUSE ROAD

SOMERSET, NJ 08873

Phone: 732-537-6200

Fax: 732-537-6480

Web: http://www.catalent.com

Email: investors@catalent.com

Industry Medical - Drugs
Sector Medical
Fiscal Year End June
Last Reported Quarter 6/30/2022
Earnings Date

This is a confirmed date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/29/2022

EPS Information

Current Quarter EPS Consensus Estimate 1.13
Current Year EPS Consensus Estimate 3.79
Estimated Long-Term EPS Growth Rate 16.50
Earnings Date

This is a confirmed date of earnings release. Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web site, including, but not limited to Information originated by Zacks Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Information Providers, or gathered by Zacks Investment Research, Inc. from publicly available sources. There may be delays, omissions, or inaccuracies in the Information.

8/29/2022

Price and Volume Information

Zacks Rank Premium
Yesterday's Close 109.94
52 Week High 142.64
52 Week Low 86.34
Beta 1.28
20 Day Moving Average 981,703.38
Target Price Consensus 140.90

CTLT

% Price Change
4 Week 9.72
12 Week 10.24
YTD -14.13
% Price Change Relative to S&P 500
4 Week -1.15
12 Week 2.21
YTD -2.72
Share Information
Shares Outstanding (millions) 179.21
Market Capitalization (millions) 19,702.70
Short Ratio NA
Last Split Date NA
Dividend Information
Dividend Yield 0.00%
Annual Dividend $0.00
Payout Ratio 0.00
Change in Payout Ratio 0.00
Last Dividend Payout / Amount NA / $0.00

Fundamental Ratios

P/E
P/E (F1) 26.17
Trailing 12 Months 28.86
PEG Ratio 1.59
EPS Growth
vs. Previous Year 28.21%
vs. Previous Quarter 17.65%
   
Sales Growth
vs. Previous Year 20.86%
vs. Previous Quarter 4.60%
   
Price Ratios
Price/Book 4.25
Price/Cash Flow 23.16
Price / Sales 4.19
ROE
6/30/22 NA
3/31/22 15.07
12/31/21 14.93
ROA
6/30/22 NA
3/31/22 6.45
12/31/21 6.29
Current Ratio
6/30/22 NA
3/31/22 2.89
12/31/21 2.85
Quick Ratio
6/30/22 NA
3/31/22 2.25
12/31/21 2.19
Operating Margin
6/30/22 NA
3/31/22 13.66
12/31/21 13.43
Net Margin
6/30/22 NA
3/31/22 10.72
12/31/21 12.94
Pre-Tax Margin
6/30/22 NA
3/31/22 13.10
12/31/21 16.89
Book Value
6/30/22 NA
3/31/22 25.85
12/31/21 25.02
Inventory Turnover
6/30/22 NA
3/31/22 4.88
12/31/21 4.91
Debt-to-Equity
6/30/22 NA
3/31/22 0.90
12/31/21 0.94
Debt to Capital
6/30/22 NA
3/31/22 47.30
12/31/21 48.33